Skip to main content

Advertisement

Log in

A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9

  • Research Article
  • Theme: Recent Advances in Musculoskeletal Tissue Engineering
  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

Employing cost-effective biomaterials to deliver chemically modified ribonucleic acid (cmRNA) in a controlled manner addresses the high cost, safety concerns, and lower transfection efficiency that exist with protein and gene therapeutic approaches. By eliminating the need for nuclear entry, cmRNA therapeutics can potentially overcome the lower transfection efficiencies associated with non-viral gene delivery systems. Here, we investigated the osteogenic potential of cmRNA-encoding BMP-9, in comparison to cmRNA-encoding BMP-2. Polyethylenimine (PEI) was used as a vector to increase in vitro transfection efficacy. Complexes of PEI-cmRNA (encoding BMP-2 or BMP-9) were fabricated at an amine (N) to phosphate (P) ratio of 10 and characterized for transfection efficacy in vitro using human bone marrow stromal cells (BMSCs). The osteogenic potential of BMSCs treated with these complexes was determined by evaluating the expression of bone-specific genes as well as through the detection of bone matrix deposition. It was found that alkaline phosphatase (ALP) expression 3 days post transfection in the group treated with BMP-9-cmRNA was significantly higher than that in the group that received BMP-2-cmRNA treatment. Alizarin red staining and atomic absorption spectroscopy demonstrated enhanced osteogenic differentiation as evidenced by increased bone matrix production by the BMSCs treated with BMP-9-cmRNA when compared to cells treated with BMP-2-cmRNA. In vivo studies showed increased bone formation in calvarial defects treated with the BMP-9-cmRNA and BMP-2-cmRNA collagen scaffolds when compared to empty defects. The connectivity density of the regenerated bone was higher (2-fold-higher) in the group that received BMP-9-cmRNA compared to BMP-2-cmRNA. Together, these findings suggest that cmRNA-activated matrix encoding osteogenic molecules can provide a powerful strategy for bone regeneration with significant clinical translational potential.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29:2520–6.

    Article  PubMed  PubMed Central  Google Scholar 

  2. DeWitt N. Bone and cartilage. Nature. 2003;423:315.

    Article  CAS  Google Scholar 

  3. Griffith LG, Naughton G. Tissue engineering—current challenges and expanding opportunities. Science. 2002;295:1009.

    Article  CAS  PubMed  Google Scholar 

  4. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, et al. Characterization of the distinct orthotopic bone-forming activity of 14 B.P. using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004;11:1312–20.

    Article  CAS  PubMed  Google Scholar 

  5. Yang J, Shi P, Tu M, Wang Y, Liu M, Fan F, et al. Bone morphogenetic proteins: relationship between molecular structure and their osteogenic activity. Food Scie Human Wellness. 2014;3:127–35.

    Article  Google Scholar 

  6. Riew KD, Wright NM, Cheng S, Avioli LV, Lou J. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int. 1998;63:357–60.

    Article  CAS  PubMed  Google Scholar 

  7. Sandhu HS, Khan SN, Suh DY, Boden SD. Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview. Eur Spine J. 2001;10 Suppl 2:S122–31.

    PubMed  PubMed Central  Google Scholar 

  8. M.P. Bostrom, N.P. Camacho, Potential role of bone morphogenetic proteins in fracture healing, Clin. Orthop. Relat. Res., (1998) S274-282

  9. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med. 2008;2:1–13.

    Article  CAS  PubMed  Google Scholar 

  10. Fujioka-Kobayashi M, Sawada K, Kobayashi E, Schaller B, Zhang Y, Miron RJ. Recombinant human bone morphogenetic protein 9 (rhBMP9) induced osteoblastic behavior on a collagen membrane compared with rhBMP2. J Periodontol. 2016;87:e101–7.

    Article  PubMed  Google Scholar 

  11. Nohe A, Keating E, Knaus P, Petersen NO. Signal transduction of bone morphogenetic protein receptors. Cell Signal. 2004;16:291–9.

    Article  CAS  PubMed  Google Scholar 

  12. Kawabata M, Chytil A, Moses HL. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-β receptor. J Biol Chem. 1995;270:5625–30.

    Article  CAS  PubMed  Google Scholar 

  13. Heldin CH, Moustakas A. Role of Smads in TGFbeta signaling. Cell Tissue Res. 2012;347:21–36.

    Article  CAS  PubMed  Google Scholar 

  14. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003;85-a:1544–52.

    Article  PubMed  Google Scholar 

  15. Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA, et al. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004;279:32941–9.

    Article  CAS  PubMed  Google Scholar 

  16. Wang Y, Hong S, Li M, Zhang J, Bi Y, He Y, et al. Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res. 2013;31:1796–803.

    PubMed  Google Scholar 

  17. Kirsch T, Sebald W, Dreyer MK. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Biol. 2000;7:492–6.

    Article  CAS  PubMed  Google Scholar 

  18. Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L, et al. Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem. 2005;280:25111–8.

    Article  CAS  PubMed  Google Scholar 

  19. Lamplot JD, Qin J, Nan G, Wang J, Liu X, Yin L, et al. BMP9 signaling in stem cell differentiation and osteogenesis. American J Stem Cells. 2013;2:1–21.

    CAS  Google Scholar 

  20. Winn SR, Hu Y, Sfeir C, Hollinger JO. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev. 2000;42:121–38.

    Article  CAS  PubMed  Google Scholar 

  21. Carragee EJ, Chu G, Rohatgi R, Hurwitz EL, Weiner BK, Yoon ST, et al. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J Bone Joint Surg Am. 2013;95:1537–45.

    Article  PubMed  Google Scholar 

  22. Elangovan S, Khorsand B, Do A-V, Hong L, Dewerth A, Kormann M, et al. Chemically modified RNA activated matrices enhance bone regeneration. J Control Release. 2015;218:22–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Balmayor ER, Geiger JP, Aneja MK, Berezhanskyy T, Utzinger M, Mykhaylyk O, et al. Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats. Biomaterials. 2016;87:131–46.

    Article  CAS  PubMed  Google Scholar 

  24. Kormann MSD, Hasenpusch G, Aneja MK, Nica G, Flemmer AW, Herber-Jonat S, et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat Biotechnol. 2011;29:154–7.

    Article  CAS  PubMed  Google Scholar 

  25. Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood. 2006;108:4009.

    Article  CAS  PubMed  Google Scholar 

  26. Elangovan S, D’Mello SR, Hong L, Ross RD, Allamargot C, Dawson DV, et al. The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factor. Biomaterials. 2014;35:737–47.

    Article  CAS  PubMed  Google Scholar 

  27. Xu DJ, Zhao YZ, Wang J, He JW, Weng YG, Luo JY. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Rep. 2012;45:247–52.

    Article  CAS  PubMed  Google Scholar 

  28. Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cell Mater. 2012;23:13–27.

    Article  CAS  PubMed  Google Scholar 

  29. D’Mello SR, Elangovan S, Hong L, Ross RD, Sumner DR, Salem AK. A pilot study evaluating combinatorial and simultaneous delivery of Polyethylenimine-plasmid DNA complexes encoding for VEGF and PDGF for bone regeneration in calvarial bone defects. Curr Pharm Biotechnol. 2015;16:655–60.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Seib FP, Franke M, Jing D, Werner C, Bornhäuser M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol. 2009;88:257–71.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by an NIH R21 grant (1R21DE024206-01A1), the University of Iowa Start-up Grant, the ITI Foundation for the Promotion of Implantology, Switzerland (ITI Research Grant No. 855 2012), the Osteology Foundation Grant (12–054), the Sunstar—American Academy of Periodontology Foundation Research Fellowship, and the Lyle and Sharon Bighley Professorship. The authors would like to thank Ryan D. Ross and Rick Sumner for their assistance in obtaining MicroCT images. Rush University Medical Center MicroCT/Histology Core resources were used. We also would like to thank Chantal Allamargot for technical support with histological image acquisition. Imaging equipment at the University of Iowa Core Microscopy Research Facility was used.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Satheesh Elangovan or Aliasger K. Salem.

Additional information

Guest Editor: Aliasger K. Salem

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khorsand, B., Elangovan, S., Hong, L. et al. A Comparative Study of the Bone Regenerative Effect of Chemically Modified RNA Encoding BMP-2 or BMP-9. AAPS J 19, 438–446 (2017). https://doi.org/10.1208/s12248-016-0034-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-016-0034-8

KEY WORDS

Navigation